Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine granules OD vs TID in active ulcerative colitis
NCT00449722Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative colitis (UC), sponsored by Dr. Falk Pharma GmbH. Started Jul 2005; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00449722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449722.